Gene expression databases contain invaluable information about a range of cell states, but the question "Where is my gene of interest expressed?" remains one of the most difficult to systematically assess when relevant data is derived on different platforms. Barriers to integrating this data include disparities in data formats and scale, a lack of common identifiers, and the disproportionate contribution of platform to the 'batch effect'. There are few purpose-built cross-platform normalization strategies, and most of these fit data to an idealised data structure, which in turn may compromise gene expression comparisons between different platforms. YuGene addresses this gap by providing a simple transform that assigns a modified cumulative proportion value to each measurement, without losing essential underlying information on data distributions or experimental correlates. The Yugene transform is applied to individual samples and is suitable to apply to data with different distributions. Yugene is robust to combining datasets of different sizes, does not require global renormalization as new data is added, and does not require a common identifier. YuGene was benchmarked against commonly used normalization approaches, performing favourably in comparison to Quantile (RMA), z-score or rank methods.
The problem of comparing different datasets has been addressed most successfully to date using ranknormalization approaches, for example by ranking Z-score values (12) , as exemplified by the Tuberculosis database TBDB (13) . Indeed, rank based approaches have been adopted generally for cross-platform analyses, but loss of relative expression can result in compressed 'fold changes', thus introducing potential biases in downstream comparative analyses (12) . Once again, cross platform strategies most commonly compare post-analyzed data, rather than attempt to integrate primary information for direct comparisons. Nevertheless, systematic integration of primary data from multiple sources should be possible, despite the technical difficulties.
Proof-of-principle that robust tissue-specific and cell-type specific gene signatures can be derived across a range of public experimental datasets can be found in expression atlases such as ArrayExpress (14, 15) .
Many of the most useful expression atlas approaches rely on data derived on a single technical platform, typically even avoiding direct comparison between different versions of the same platform. BioGPS (16) and the Gene Expression Commons (17) for example use data derived on the Affymetrix Genechip platform. Similarly, Pluritest (18) provides an example of a tool that benchmarks stem cell signatures generated on a specific version of the Illumina microarray platform. By relying heavily on a single platform, these large atlas projects face the very real danger of premature technical redundancy because of the rapid pace of technological change. While new atlas approaches are being scaled to interrogate genes across libraries of tissues or cells (19) (20) (21) , it is arguably impossible to reproduce the variety of cell-states currently available in gene expression repositories such as ArrayExpress, or the Gene Expression Omnibus (GEO), particularly when one considers scarce patient-derived materials, or material from models that rely on knock-down or over-expression of target genes. This is exemplified by the sheer volume of available data: for example, there are now more than 4000 platforms listed in GEO for querying the human transcriptome, and these have generated in excess of 500,000 experimental samples (22) .
Therefore we need to continue to develop robust approaches for data integration, which can evaluate genuine biological patterns of gene expression across data derived from many different technical and experimental sources.
In the current study, we address two of the major limitations of current cross-platform normalization methods: the requirement for identical identifiers, which excludes or limits analysis from platforms with different probe-set identities; and the difficulties in merging datasets derived using different scales of measurements, such that datasets measuring different numbers of unique measurements, or generating different types of outputs cannot be easily compared. Our approach, 'YuGene', addresses the major ! 4! barriers identified above by accurately capturing relative intensity information using a modified cumulative proportion, which allows for a simple and robust method by which to directly compare different probes for a gene, and to compare samples within and between experiments. YuGene does not address all of the possible experimental confounders in a cross-platform meta-analysis, but it reduces the impact of technical batch on combined expression data. We demonstrate the utility of our approach to identify genes that are highly enriched in stem cell populations, using the www.stemformatics.org platform. 
where ! ! is the YuGene transformed value for probe ! , ! ! is the pre-processed raw value for probe ! (see following section 2.a and S1), ! is total number of probes on the array and
The output for each probe ! ! is a value between zero (lowest expression) and close to one (highest A 'tie' is considered when equivalent values occur in the raw data, for example ! ! = ! !!! , and the same YuGene value is assigned to each member of the tie such that
Preprocessing steps
YuGene was benchmarked against raw data and other types of data transformation including quantile normalized (RMA), COMBAT, rank and z-score, detailed below.
a.
Normalization. The preprocessing step involved a background correction and a log2 transformation of the raw values. Any 'raw' data values subsequently shown were log2 transformed and background corrected without further normalization. Pseudo code of the preprocessing steps is available in S1. Each dataset was preprocessed using an appropriate package from R/Bioconductor; Affymetrix arrays were handled with affy (23) (http://www.bioconductor.org/packages/release/bioc/html/affy.html) or oligo (24) (http://www.bioconductor.org/packages/release/bioc/html/oligo.html) and Illumina arrays were handled with lumi (http://www.bioconductor.org/packages/release/bioc/html/lumi.html) and the parameters ! 6! used are described in detail in S1. Quantile normalization was performed using the preprocessCore package (25) . Where appropriate, COMBAT (26) was applied using the sva R package (http://www.bioconductor.org/packages/release/bioc/html/sva.html). Rank or z-score transformations were applied using the rank and scale functions (respectively) available in the R core base package (27) . No subsequent analysis was run on individual Affymetrix probes, but all analyses were run at the summary probeset level. To avoid using platform-specific nomenclature, from this point expression values from an Affymetrix probeset are referred to simply as 'probe' b.
Mapping. Where a common identifier was required to compare the behavior of different normalization methods, the Ensembl gene identifier was used. When several probes from the same platform mapped to the same Ensembl gene ID, then the probe with the highest average expression was arbitrarily chosen to represent the gene.
c. Detection threshold. Where stated, the detection threshold was applied at the probe level on each raw dataset independently. The threshold was defined so that i) 20% of the probes were removed
and ii) more than 1/3 of the samples had these probes under the detection threshold.! !
Datasets used
Three different types of microarray data were used to benchmark YuGene.
a. Simulated data A first benchmark was performed on simulated data. YuGene transformation was compared to RMA (quantile normalization). The simulated data took its distribution from an Affymetrix study. Several data sets X were generated with n = 100 samples and p = 12,822 genes. In each of these data matrices, we simulated two types of cells (biological effect) and five types of batch (technical effect). Each condition (cell-type or batch effect) was randomly assigned to a sample. The expression of 12K genes were simulated, amongst which 10% had a true biological effect, (cell type) and 10% had a study (batch) effect.
A possible overlap between these differentially expressed (DE) genes due to either a true biological effect and a batch effect was allowed. The code used to generate this data, and the simulated dataset itself is provided in Supplemental file S2-1 (Zip).
b. MAQC microarray data
The MicroArray Quality Control MAQC project was used as the community standard for assessment of intra and inter-platform variability of microarrays (1) (29)). The data were scaled prior to the analysis to obtain comparable and unbiased variances of the random effect between each tested method.
c. Principal Component Analysis (PCA).
PCA was performed on the first 2 principal components. Each data set was centered on the probes or genes and the graphs were obtained using the R package mixOmics (http://perso.math.univtoulouse.fr/mixomics/).
d. Correlation
The concordance between technical replicates normalized with different methods was assessed using the Pearson's correlation coefficient between each pair of technical replicates. Additional details are provided in S3.
Implementation in Stemformatics
The YuGene transform was applied to all gene expression microarray datasets housed in Stemformatics.
Probe-level YuGene expression values are stored in an in-memory lookup table for fast query access. YuGene graphs are returned on the GeneSearch page, or can be navigated to via the Geneview menus.
RESULTS

YuGene preserves major features of data distributions
YuGene is a scaling method, in contrast to quantile normalization methods that fit the data to an idealized distribution, or rank transformations that ignore the distribution of the underlying data altogether. A comparison of the density distributions of these common strategies ( Figure 1 ) is provided for a typical Affymetrix microarray sample. While both YuGene and the rank transformation resulted in a more linear probit function shape than z-score or RMA normalized data, YuGene retained more information about the underlying distribution than the ranked approach. YuGene was tolerant of different types of distributions, scaling but not imposing an identical fit. This is further shown in the density plots in S2 for a comparison of several real-world microarray studies taken from 6 different platforms (described in Table 2 ).
Scaling expression data using a YuGene transformation did result in compression of normalized values at the tails of the range of measurements taken. This is illustrated in Figure for Affymetrix platforms, both on detection-thresholded data), a trend confirmed for biological replicates from a number of additional datasets.
YuGene is tolerant of different sized datasets.
Allowing the inclusion of different identifiers will permit the inclusion of different sized datasets in a comparative series. Figure 3 illustrates the severe impact that the number of probes has on the distribution of raw, quantile normalized and z-score transformed data, with a marked difference in Wilcoxon p-values observed even when 70% of the probes are retained. In contrast, Yugene transformed data was minimally impacted by changes to the number of probes sampled, indicating that the number of probes is not a major confounder when implementing YuGene. This property of YuGene is particularly useful for comparing platforms with large differences in the number of features.
YuGene reduces the 'batch' effect.
YuGene is applied to each individual sample, which means new data can be combined without the need for renormalization across the series. However most normalization procedures are applied across an experimental series in order to reduce technical (or batch) variation. We used Principal Component Analysis to provide a useful visualization for combined data treated with different normalization methods, in order to assess whether the proportion of variance in the dataset that could be attributable to technical or biological effects. We further assessed the ability of YuGene to reduce the contribution of batch by combining several stem cell experiments, generated across multiple platforms in different laboratories, and sourced from the Stemformatics database (described in Table 2 ). Figure 5 (and S7) shows clear segregation between fibroblast and pluripotent stem cell types with all the normalization approaches, except for COMBAT, which required two PCA components to resolve the major biological clusters.
Thus YuGene was effective at reducing the impact of platform and laboratory source in multiple situations.
In both scenarios -the highly technically controlled experiments (MAQC) and the merger of multiple public datasets -YuGene transformed data reduced experimental (batch) variability without loss of genuine biological variance.
YuGene transformed data is suitable for differential expression analysis
A linear mixed model was used to discern the accuracy of a differential expression analysis, using data simulated to have varying noise or batch effects. Cell type was treated as a fixed effect and batch as a random effect. Significance was assessed using a false discovery rate of 1%. As can be seen from Table   S4 , YuGene and Quantile normalized data returned similar percentages of Type I and Type II errors, with
YuGene transformed data resulting in fewer Type I errors, but slightly higher false-negative rate than Quantile normalized data. Batch was easily dealt with in all cases, and unsurprisingly neither method worked well when the noise between technical replicates was modeled to be high.
Given the relative consistency of the two normalization methods on simulated data, concordance was assessed across the 18 MAQC samples, where batch included six laboratory sites and two microarray platforms (Affymetrix and Illumina). Differences were assessed between two biological sample types -A:
the Universal human reference vs. B: human Brain. The model included site, reference and platform as fixed effects and the technical or biological replicates as random effects. Table 3 (and Figure S5) shows a high degree of overlap of differentially expressed genes was identified in YuGene or quantile normalized data. YuGene identified 6061 differentially expressed genes, of these 17% (1032 genes) could be attributed to a biological effect alone. Although more differentially expressed genes were predicted in the Quantile or Z-score normalized data, the technical effects accounted for a higher proportion.
Following the analysis on the MAQC technical replicates, the next step was to perform a differential analysis across several stem cell datasets described in Table 2 . A linear mixed model was used, but the experimental source was treated as a random effect to allow us to quantify the amount of variance due to ! 11! the batch effect. The Venn Diagram in Figure 6 illustrates the overlap between the gene sets identified by each transformation, and the variance due to the batch effect was summarized in the boxplots. This was significantly less in the YuGene transformed data than in Quantile (one-sided t-test, p-value = 6.261e-8 and 4.544e-11 for (b) and (c)). See also S6 for more details.
In all three scenarios, YuGene transformed data reduced the contribution of technical variance, and returned fewer false positives than the other normalization strategies.
To further assess the influence of the YuGene compression of the high values, differential expression analyses were performed on the Guenther data set (30) (See Table 2 
!
Application of YuGene to the Stemformatics database
The original motivation for development of the YuGene transform was the desire of Stemformatics.org users to query the behavior of an individual gene across multiple datasets. This frames the "where is my gene of interest expressed" question, one that is repeatedly requested by biologists wishing to ascertain whether patterns derived from their own data or observations can be recapitulated across the multiple unrelated datasets housed in Stemformatics (31).
Stemformatics currently houses fifty-four different data types, including twenty-eight different microarray chip-types that can be summarized into eight 'platforms' servicing mouse or human stem cell data (Table   4) . Probes whose behavior is poor compared to the probeset to which they belong are flagged to allow users to remove these from downstream analyses. For example, Table 4 lists the % of probes on each platform that always sit 2 fold below the expression of other probes mapping to the same gene, and that are always expressed below the 3 rd quartile of any probe. These might be considered to be poorly hybridizing probes, or probes directed to a transcript that is not commonly expressed and not seen in the samples that we have survey. Probes that do not vary in YuGene profile across the Stemformatics samples are excellent candidates for housekeeping controls in subsequent validation experiments. An example is given in Figure 7a , for the housekeeping gene ACTB. Probes that are positively skewed are expressed at a high level are considered to be commonly expressed across the majority of Stemformatics samples, likewise probes that are negatively skewed are considered to have a restricted pattern of expression, and may be cell-type specific. An example of the former is POU5F1 (Figure 7b ), and the latter is illustrated by Figure 7c (DNMT3L). As with any bioinformatics analysis, the YuGene transform does not remove the necessity to validation predictions made from cross-platform analysis. However by examining patterns that are reproducible across many datasets, the focus of this validation can be on high-confidence targets.
Advantages of the YuGene Transform
(i) No need for common probe identifiers. Most normalization strategies impose the requirement of common identifiers, which may necessitate the building of a minimal convergent dataset. Even when mapping probes from the most popular array platforms to a common annotation such as the same reference gene, the overlap between any two platforms was in the order of 60 -70% (33, 34) . YuGene therefore preserves considerable information when combining multiple datasets. Retaining unique identifiers provides opportunities to systematically evaluate concordant and divergent data at a probe level within a platform, and between platforms. As can be seen in Table 4 , each platform contains a small percentage of poorly performing probes, whose expression was flagged as consistently low and discordant with its associated probeset. The expression of most probes, regardless of platform, was normally distributed -consistent with the assumptions that a large proportion of genes are expressed in a large proportion of cell types/samples. Likewise, relatively few probes demonstrated highly skewed patterns of expression. Evaluation of probe performance across many samples, and concordance within an experimental series, provides an important tool for users to filter out probes that may be uninformative ! 13! or exaggerate platform differences. This is only possible if every measurement can be retained in the normalization process.
(ii) Stand-alone single-sample normalization. YuGene does not require renormalization every time a new sample is added to the experimental series, thus simplifying workflows and protecting the integrity of existing analyses, which may be otherwise affected by renormalization. This has been previously recognized as an important advantage for optimizing cross-experimental analyses (9,10).
(iii) Keep the relationships between probes. YuGene retains the correlation structure between probes, and between samples for a single dataset. While some downstream analyses may assume independence between the measurements taken for a given dataset (for example, gene set enrichment analyses (35)), other analysis approaches exploit this correlation structure (for example transcript splicing indices or eQTL analysis (36-38)). We therefore argue that this should be explicitly examined, and the probe- (iv) Reduce technical variation, keep genuine biological differences. Differential expression analysis across platforms requires evaluation of possible technical confounders, regardless of the normalization method used. In our hands, using simulated data, or technically controlled MAQC data, or data generated from the combined Stemformatics.org website, the YuGene transform returned high quality differential expression predictions, and generally had reduced type I error compared to the other methods. By including technical sources of variation in our linear models, we were able to show a reduction in genes assigned as differentially expressed in the 'noise' class. We also showed using PCA that YuGene transformed data reduced the variance imposed by platform or batch, in contrast to the other transformations that we benchmarked against. We speculate that the compression of data at the tails of a YuGene scale may contribute to this biological stability, particularly if differences in the absolute linear range of measurements taken on different platforms were a major contributor to small variation in these tails.
(v) Permit different platforms to have different linear ranges. Each platform generates data with a range of values that is highly dependent on experimental parameters such as probe deposition, the flurophore or colormetric assay used, the scanner resolution, and site-site variation is scanner settings (39) . A gene may be measured as highly expressed in two experiments but may be assigned two different values due ! 14! to technical differences in the platforms, making a direct comparison impossible to perform. Certainly all microarray hardware has an upper and lower linear range of reliable measurements, but although the field is familiar with thresholding data on detection limits, it is relatively uncommon to threshold data that may have exceeded the upper limits of the detection spectrum (40) . By rescaling data to a common range, YuGene does compress the values that sit at the high or low extremes of a distribution. However, we have shown that this compression does not seem to affect the results of the subsequent statistical analysis. The compression of the expression values may in fact reduce false positives due to platform differences in scale, providing a more meaningful direct comparison of these extreme measurements.
(vi) Speed and ease of implementation. YuGene is computationally quick and easy to implement, requires implementation only once per sample, and scales across large series of experiments so is suitable for database implementation.
Caveats and cautions when using YuGene
YuGene rescales data, and this results in a compression of values that sit at the very extreme of a distribution. YuGene may be adversely impacted by the presence of a high number of undetected probes.
We observed in some cases that the correlation between technical replicates was improved when undetected probes were removed prior to applying the YuGene transform. This was particularly apparent for Illumina microarray data ( Figure S3 ), but provided no apparent benefit for others (Table S3 ).
The normal caveats regarding interpretation of downstream analyses across multiple independently generated samples must also apply to YuGene transformed data. No transformation can correct poor experimental design, inappropriate comparisons, or major differences in the handling of the biological processes being evaluated. Although YuGene was effective at reducing technical artifact, it was not able to completely remove platform-generated batch effects that may mask genuine biological differences, meaning that some differentially expressed calls might appear as a result of a batch effect. However, YuGene was able to remove the experimental bias previously reported in a meta-analysis of several different stem cell experiments (41) , and demonstrates that robust data transformation prior to analysis (YuGene or Quantile in this instance) will reduce the influence of the technical sources of variation on downstream data analysis. YuGene was also effective at minimizing type I error in our simulated datasets, but did return higher type II errors as a result.
CONCLUSION
YuGene is a simple data transformation that is applied to individual samples, which allows for the serial 
